Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition

Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique

A combined body scan technique for measuring total energy expenditure (TEE) from energy intake and changes in energy stores is presented. The TEE of 13 patients with Crohn's disease who required nutrition support over a 14-day period was measured. They had a mean TEE of 33 kcal/kg per day. The components of the TEE in these 13 patients were also measured. Seventy percent of the TEE was made up by resting metabolic expenditure, 10% by diet-induced thermogenesis, and the remaining 20% by activity energy expenditure. These patients had a mean activity energy expenditure of 369 kcal/day. The diet-induced thermogenesis was a mean 12.6% increase on the resting metabolic expenditure. Each percent increase was caused by a mean of 210 kcal of energy in either the intravenous nutrition or the enteral nutrition. There was no difference in diet-induced thermogenesis between those having enteral nutrition and those receiving intravenous nutrition. Decreased activity was significantly correlated with increased activity of the disease (r = .7, p < .01). This confirms the belief that patients with Crohn's disease require no more energy (ie, 33 kcal/kg per day) than other patients. If the resting metabolic expenditure is increased through illness, then the activity energy expenditure decreases. The combined in vivo neutron activation-dual energy x-ray absorptiometry technique has allowed for the first time measurements in ward patients with Crohn's disease. The measurements confirm that TEE is not raised and that 30 to 35 kcal/kg per day is sufficient to achieve energy balance in such patients.

Prediction of fat-free mass in black and white pre-adolescent and adolescent girls from anthropometry and impedance

As an ancillary project of the National Heart Lung and Blood Institute's Growth and Health Study (NGHS), data of 31 black girls and 38 white girls, 10-16 years of age, were used to develop equations to predict fat-free mass (FFM) from selected anthropometric dimensions and bioelectric impedance measures of resistance and reactance. Subjects were drawn from ongoing projects at the Children's Hospital Medical Center (CHMC) to obtain girls of both races from a wide range of body mass indices. FFM was estimated from measures of dual energy X-ray absorptiometry (DXA). The resulting equations had a root mean square error (RMSE) of 1.9 kg and a coefficient of variation (CV) of 4.9% for black girls using independent variables: stature divided by resistance squared (S² /R), thigh circumference, subscapular and suprailiac skinfold thicknesses. The corresponding values for white girls were 1.1 kg and 3.2% using independent variables: S² /R, arm circumference, weight, and reactance divided by resistance (R/R_c ). In addition to cross-validating the ethnic-specific equations using PRESS statistics, the equation for white girls was also cross-validated using an independent sample of 35 girls from the Fels Longitudinal Study selected to match the CHMC sample. The cross-validation yielded a pure error of 2.4 kg FFM and a CV of 7%. The predicted values for FFM from the equations were used to calculate percentage of body fat in the CHMC sample and the pure errors for estimating percentage of body fat were 3% for blacks and 2% for whites. © 1993 Wiley-Liss, Inc.

Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy

OBJECTIVE

We assessed the effects of the administration of low dose growth hormone in growth hormone deficient adults on body composition and physical performance. We compared the validity of different measures of body composition in GH treated adults.

DESIGN

An uncontrolled longitudinal study of eight patients with GH deficiency who were treated with 4 units of biosynthetic growth hormone (Norditropin), three times a week. Subjects were studied for 8 weeks.

PATIENTS

Eight patients with acquired growth hormone deficiency as defined by < 5 mU/l GH following standard provocative investigations in whom other hormone replacement was optimized.

MEASUREMENTS

IGF-I was measured on day 1 and after 4 and 8 weeks of treatment with recombinant human growth hormone. Body composition was estimated by dual energy X-ray absorptiometry, bioelectrical impedance, skinfold anthropometry, total body potassium measurement and by computerized tomography of a representative cross-sectional area of thigh on day 1 and following 8 weeks of treatment. Exercise capacity was measured on an electromechanical bicycle and palmar grip strength was measured using a Jamar dynamometer on day 1 and after 8 weeks.

RESULTS

IGF-I increased significantly. Exercise capacity and maximum heart rate achieved on the electromechanical bicycle increased significantly. Grip strength did not change. There was a significant increase in fat-free mass and a decline in fat mass as shown by dual energy X-ray absorptiometry and bioelectrical impedance. However, this was not confirmed by other methods. No side-effects were noted.

CONCLUSIONS

This study shows that a low dose of biosynthetic growth hormone can elevate IGF-I levels and have a pronounced physical impact in the growth hormone deficient adult without the side-effects seen at higher dosage schedules. Over a 2 month period the increase in fat-free mass may be due to an increase in total body water; however, the decline in fat mass is a genuine effect.

Endogenous sex hormones and bone mineral density among community-based postmenopausal women

In order to describe the relationships between endogenous sex hormones and bone mineral density in healthy postmenopausal women, we carried out a cross-sectional study of 90 community-based women, all at least one year since their last menstrual period (mean 9.6 +/- 4.9 years, range 1-22) and with a serum oestradiol level less than 100 pmol/l. None was currently using hormone replacement therapy. Serum oestradiol, testosterone, sex hormone binding globulin, dehydroepiandrosterone sulphate, and androstenedione were measured using standard techniques. Free oestradiol and testosterone indices were derived as the ratio of total hormone to sex hormone binding globulin, respectively. Total body, spine and hip bone mineral density (g/cm2) were measured by dual energy X-ray absorptiometry. Significant positive correlations were found between the free oestradiol and testosterone indices and bone mineral density at all sites. These relationships remained significant for the free oestradiol index after adjustment for age and body mass index. By stepwise multiple regression analysis, the free oestradiol index was an independent predictor of total body, spine and hip bone mineral density, accounting for 4-17% of the variance. These findings suggest an independent positive relationship between endogenous free oestradiol and total body, spine and hip bone mass even in the late postmenopause.

Determination of bone mineral density by dual x-ray absorptiometry in patients with uncemented total hip arthroplasty

Bone remodeling is an expected sequela with total hip arthroplasty (THA). Although there are several methods of estimating bone response in THA patients from radiographs, there are no accurate and generally accepted methods for quantitative determinations in vivo. In this study, we describe an application of dual x-ray absorptiometry (DXA) for measuring bone mineral content and bone mineral density in the proximal femur following THA. DXA is a noninvasive technique with minimal radiation exposure (< 5 mrem). Various aspects of measurement error (accuracy and reliability) of this application of DXA were determined in a series of studies reported here. Accuracy error (how similar are the measured and actual values) was < 1% determined in bone phantoms of four densities. Precision error (how reproducible are the measurements) was also < 1% at all four densities in the phantoms and was only slightly elevated (0.9-1.5%) in repeated measurements of implanted cadaver femora. Precision error in vivo, determined both from multiple replicates on five patients and from duplicate scans on 30 patients, was further elevated but remained < 5%. Contributions to precision error, rotation of the leg, and interoperator variability were assessed; none was found to elevate precision error appreciably. We suggest that DXA is a feasible method for quantifying bone response following THA, and will allow discrimination of small changes (> 5%) not previously measurable.

Body composition and bone mass in post-menopausal women

OBJECTIVE

We aimed to assess total body composition and to study the interrelationships between fat and lean tissue mass with total and regional bone mass in healthy British post-menopausal women.

DESIGN AND PATIENTS

Total body composition and regional bone mass were measured in 97 healthy post-menopausal women recruited from the general community. The mean age was 57.9 years, range 49-65.

MEASUREMENTS

Total body composition (fat, lean tissue and bone mineral) and regional bone density in the lumbar spine and femur were measured by dual energy X-ray absorptiometry on a Lunar DPX.

RESULTS

Significant negative correlations with age were found for total body bone mineral density (r = -0.200, P = 0.049), and lumbar spine bone mineral density (r = -0.28, P = 0.006); the calculated rate of bone loss from these two sites was 0.33 and 0.7% per annum respectively. Fat tissue mass showed a positive correlation with age (r = 0.22, P = 0.03). High correlations were observed between total body and regional bone mineral density (r = 0.755-0.829, P < 0.001). After adjustment for age and lean mass, statistically significant correlations were seen between fat tissue mass and all bone mass measurements (P < 0.01-0.001), the strongest correlations being found for total body bone mineral content and density (r = 0.477 and 0.488 respectively). Lean tissue mass showed a strong correlation with total body bone mineral content (r = 0.580, P < 0.001), after adjustment for age and fat mass; it was less strongly correlated with other bone mass measurements than fat mass, showing only weak correlations with total body, trochanteric and lumbar spine bone mineral density (r = 0.228-0.246, P < 0.05). Age-adjusted body weight showed stronger correlations with total and regional bone mass than did either body mass index or height.

CONCLUSIONS

Both fat and lean tissue mass are related to total and regional bone mass in post-menopausal women, the relationship being strongest for fat mass. Body weight shows stronger correlations with bone mass than either height or body mass index. In view of the direction and magnitude of changes in fat, lean tissue and bone mineral after the menopause, adiposity and muscularity are more likely to be determinants of peak bone mass than of the rate of post-menopausal bone loss.

Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis

To evaluate the influence of hydration status on the estimation of body composition using dual-energy X-ray absorptiometry (DXA), six normal volunteers and seven patients on maintenance haemodialysis were investigated using two different DXA machines (Lunar DPX, Hologic QDR 1000/W). Normal volunteers were studied (Hologic QDR 1000/W) before and 1 h after ingestion of breakfast, lunch and dinner (drinking various amounts of liquids at each meal, 0.5-2.4 kg). Whereas bone mineral content and body fat mass did not change, lean body mass of the trunk increased as a consequence of the meals. Conversely in patients on haemodialysis (Lunar DPX), lean body mass decreased in all segments of the body as a consequence of removal of 0.9-4.4 kg of salt-containing fluid by haemodialysis (trunk 61%, legs 30%, arms 5.5% and rest of the body 3.5%), whereas bone mineral content and body fat mass remained unchanged. However, this finding(s) did not hold true in one particular patient with bilateral hip prostheses. Measurement of body composition in eight normal volunteers on the same day with both machines showed similar results for lean and fat mass, whereas bone mineral content was found to be 17% higher using the Lunar DPX. In summary, in centres where both machines are available, follow-up of one individual patient should always be performed using the same equipment. In addition, hydration status and food intake must be taken into account when repetitive measurements of lean body mass are performed in the same patient.

A screening and counseling program for prevention of osteoporosis

Prevention of osteoporosis is an increasingly salient public health concern as our society ages. This report describes the procedures used at an osteoporosis center to which people come for screening and counseling. The patients on whom this report is based were 53 non-smoking women, 1-10 years postmenopausal at the time of their first visit to the center, who chose not to undertake estrogen therapy, and who returned for a second visit in 12-18 months. They were classified as to adequacy of calcium intake (at least 750 mg/day) and exercise (at least 3 h/week of weight-bearing exercise) at both visits; complete data on calcium intake and exercise were available on 46 of the women. Bone densities were measured at the femoral neck and lumbar spine with dual energy X-ray absorptiometry, and at the distal radius with single photon absorptiometry. At the first visit, 67% of the women reported adequate exercise and 43% reported adequate calcium intake. At the second visit, the percentages in the adequate categories had increased to 74% for exercise (p = 0.06) and 70% for calcium intake (p = 0.02). Age at the first visit was inversely correlated with femoral (r = -0.40, p = 0.003) and spinal (r = -0.36, p = 0.009) bone densities; the correlation with radial bone density did not achieve significance (r = -0.27, p = 0.55). Rather than declining, as would be expected in early postmenopausal women, bone density rose slightly, but not significantly, between visits for all three sites.(ABSTRACT TRUNCATED AT 250 WORDS)

Dual-energy x-ray absorptiometry of the forearm: reproducibility and correlation with single-photon absorptiometry

Although single-photon absorptiometry (SPA) has been the predominant tool used to assess bone mineral density (BMD) in the forearm, the development of dual-energy x-ray absorptiometry (DEXA) provides the benefits of greater source stability, reduced scanning time, and improved image resolution compared to SPA. In the present study we used the DEXA bone densitometer (Hologic, Inc., Waltham, MA) to (1) measure BMD in the one-third radius and ultradistal radius; (2) examine the reproducibility of these BMD measurements; and (3) compare the BMD at the one-third radius with SPA (SP2, Lunar Corp., Madison, WI). In 65 normal women (ages 22-74 years) we examined changes in the forearm DEXA BMD with age, revealing significant quadratic regression equations. The reproducibility of DEXA BMD (mean +/- SEM) in 7 normal subjects aged 22-50 years is 0.85 +/- 0.16% for the predominantly cortical one-third radius site and 0.97 +/- 0.15% for the more trabecular ultradistal site. The regression relationship between DEXA and SPA of the one-third radius in 26 subjects (ages 22-68 years) is DEXA BMD = 0.105 + 0.826 (SPA BMD); R = 0.97, R2 = 0.94, p less than 0.0001. Bone densitometry of the forearm using DEXA may be performed relatively rapidly, providing reproducibility and image resolution that are generally superior to those observed with SPA.

An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry

Dual-photon absorptiometry (DPA) is a well-established procedure for measuring bone mineral density (BMD). Recently, dual-energy X-ray absorptiometry (DXA) has become available, which has the ability to measure BMD both regionally and in the total body (TB). We have evaluated the in vivo and in vitro precision of a DXA instrument and compared it with a DPA instrument with similar software characteristics. The short-term precision of BMD measurements using DXA was assessed in 65 postmenopausal women who had duplicate scans performed, with repositioning between scans. Precision was 0.9% in the lumbar spine and 1.4% in the femoral neck. The midterm precision of DXA was compared with DPA by scanning 10 volunteers a mean of four times over 24 weeks, on both instruments. The precision of the bone mineral content (BMC) and area measurements was significantly better (P less than 0.05) with DXA than with DPA. Long-term in vitro precision was assessed by scanning an aluminium spine phantom over 42 weeks, and a cadaveric sample over 52 weeks, on both instruments. Precision was similar using the aluminium phantom, but was significantly improved (P less than 0.001) when using DXA for scanning the cadaveric sample. Highly significant correlations (all P less than 0.001) of BMD, BMC and area measurements were observed when 70 volunteers were scanned on both instruments. However, there was a systematic difference in BMD values between the instruments. The precision of TB composition measurements assessed in 16 volunteers, over a 16-week period, were TB BMD 0.65%, TB lean tissue 1.47%, and TB fat tissue 2.73%.(ABSTRACT TRUNCATED AT 250 WORDS)

Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass

Dual-energy X-ray absorptiometry (DEXA) has been used to assess and compare the composition of whole body and major body regions in 12 female (weight, 56.9 +/- 6.2 kg; BMI, 17-25 kg m-2) and 16 male (weight, 73.1 +/- 9.6 kg; BMI, 20-28 kg m-2) healthy subjects. Standard deviations (and % coefficients of variation) of the differences between repeated measurements of fat ranged from 0.11 kg (9.0%) for arms to 0.42 kg (3.0%) for whole body; for arm bone mineral, 0.01 kg (2.0%), and for fat-free soft tissue of the whole body, 0.42 kg (0.8%). Limb muscle mass was estimated using a new theoretical model of body composition, and the corresponding precision ranged from 0.15 kg (3.8%) to 0.27 kg (1.5%) for arms and total limb muscle mass, respectively. Proportions of each region consisting of fat were greater in females than in males (range, 20-31% vs. 16-18%), respectively, but the ratio of trunk to leg fat was lower (34:49% vs. 46:38%, respectively). Regional proportions of bone were similar between the sexes (all in the range 2.9-5.6%, for both females and males). Mean total limb muscle masses were 14.2 kg (arms, 2.8 kg; legs, 11.4 kg) for females and 22.2 kg (arms, 4.8 kg; legs, 17.4 kg) for males, which were 33.6% and 36.0% of fat-free mass, respectively. The correlation coefficients between limb muscle (DEXA) and other indices of muscle mass were: for DEXA vs. total body potassium, 0.90 (SEE 1.1 kg muscle mass) to 0.94 (1.6 kg); and for DEXA vs. anthropometry, 0.43 (1.2 kg) to 0.85 (1.3 kg). Those for limb volume (DEXA) vs. anthropometric volume, 0.91 (0.78 1) to 0.94 (1.91 1). It is concluded that DEXA enables the valid and reproducible estimation of fat, fat-free soft tissue, bone, and limb muscle mass.

Performance of dual-energy x-ray absorptiometry in evaluating bone, lean body mass, and fat in pediatric subjects

We studied the performance of the dual-energy x-ray absorptiometry method in evaluating bone mineral, fat, and lean soft tissue mass. This method was accurate in quantifying known small amounts of calcium, lard, and lean tissue mass. It was also accurate in evaluating small animal ashed bones, fat, and muscle mass. The analytic sensitivity of the method was 40 mg for calcium, 180 mg for fat, and 270 mg for lean tissue mass. The method was highly correlated to the single-photon absorptiometry method in measuring bone mineral content at the radius bone in 32 children, r = 0.998. There was a difference between the two methods in older children. Long-term precision for a small bone phantom was 2.0%. Total-body, lumbar, and radial bone scans were performed on 14 newborn infants whose gestational ages ranged from 28 to 41 weeks. Both total-body bone mineral and fat mass increased with gestational age and weight. The infant's total-body calcium was also associated with length and lumbar and radial bone densities. The lumbar bone density was associated with birth weight, gestational age, length, body mass index, body fat, and radial bone density. Male infant's lumbar bone density to total-body calcium ratio was higher than female infant's lumbar bone density ratio. Dual-energy x-ray absorptiometry may be used in pediatrics with high accuracy, sensitivity, and precision.

Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause

The reduction in cardiovascular risk induced by hormone replacement therapy is only partly explained by changes in serum lipids and lipoproteins. As body composition and body fat distribution in particular are independent predictors of cardiovascular disease, we investigated the effect of postmenopausal hormone therapy on body composition parameters directly measured. Sixty-two early postmenopausal women were followed up for 2 years in a prospective, randomized, placebo-controlled study. We found that combined estrogen-progestogen therapy prevented the increase in abdominal fat after menopause (P less than .05), and that this effect was independent of the effect on serum lipids and lipoproteins. The therapy reduced postmenopausal bone loss significantly (P less than .001), whereas it did not have a statistically significant influence on total body fat mass or total lean body mass. The findings of the present study suggest that some of the protective impact of postmenopausal hormone therapy on cardiovascular disease may be explained by the effect on body composition, in particular abdominal fat.

Dual-energy X-ray absorptiometry versus single photon absorptiometry of the radius

Radial diaphyseal bone mineral density (BMD) was measured at the standard one-third site by dual-energy X-ray absorptiometry (DEXA) and by 125I single photon absorptiometry (SPA) in 70 consecutive subjects, aged 12-86 years, with metabolic disorders of the skeleton. Each patient was measured once by the DEXA (Hologic QDR-1000) instrument and four times by the SPA (Norland 2780) instrument on the same day by one or the other of 2 technicians. The DEXA and SPA measurements were linearly related and highly correlated (r = 0.975, P less than 0.0001) over a range from severe osteopenia to high normal BMD. Ninety-five percent of the variation in the BMD determined by SPA was accounted for by DEXA, so that the BMD(SPA) = 1.035 +/- 0.027 (SEM) x BMD(DEXA)-0.007 +/- 0.019 (SEM). This permits continued use of previously accumulated SPA data-bases. The coefficient of variation for repeat measurements by DEXA was 1.2% and by SPA 1.6%. Examination time by DEXA was 6-7 minutes, about 45% shorter than the corresponding SPA determinations. DEXA is the superior method for evaluation of the radius, as it provides faster and more precise measurements in clinical practice.

Effects of body fat distribution on regional lipolysis in obesity

To determine the contribution of the major body fat depots to systemic free fatty acid (FFA) availability, palmitate ([1-14C]-palmitate) release was measured from leg (lower body) and non-leg (upper body) fat in eight upper body obese (UB Ob), six lower body obese (LB Ob), and six nonobese (Non Ob) age-matched premenopausal women in the overnight postabsorptive state. Splanchnic palmitate release was determined in 16 of these subjects.

RESULTS

total palmitate release was greater in UB Ob (P less than 0.005) than LB Ob or Non Ob women (161 +/- 16 vs. 111 +/- 9 vs. 92 +/- 9 mumol/min, respectively). Despite increased leg fat mass in obese women, leg palmitate release was similar in each group. Therefore, leg fat palmitate release was greater in Non Ob women than LB Ob (P less than 0.01) or UB Ob (P = 0.06) women (3.7 +/- 0.3 vs. 2.4 +/- 0.2 vs. 2.7 +/- 0.2 mumol.kg fat-1.min-1, respectively). Upper body fat palmitate release was less (P less than 0.01) in LB Ob than Non Ob or UB Ob women (3.0 +/- 0.4 vs. 5.0 +/- 0.3 vs. 4.9 +/- 0.4 mumol.kg fat-1.min-1, respectively). Splanchnic palmitate release accounted for 20-32% of upper body fat palmitate release in each group (P = NS between groups). Leg fat palmitate release was significantly less than upper body fat palmitate release. We conclude that the major difference in resting FFA metabolism between UB Ob and LB Ob women is the ability of the later to down-regulate upper body fat lipolysis to maintain normal FFA availability.

Validation of body composition by dual energy X-ray absorptiometry (DEXA)

The present study validates the use of dual energy X-ray absorptiometry (DEXA) for measurement of body composition. The precision error was expressed as the SD (CV%) for fat mass, FAT%, lean tissue mass, and total body bone mineral: 1.1 kg (6.4%), 1.6% (5.7%), 1.4 kg (3.1%), and 0.03 kg (1.2%), respectively. The accuracy study in vitro used (1) mixtures of water and alcohol, (2) mixtures of ox muscle and lard, and (3) dried bones. In the clinically relevant range of values there were only small influences on DEXA measurements of variations in amount and composition of the soft tissue equivalents. The accuracy study in vivo compared the components of body composition measured recently by DEXA and earlier by dual photon absorptiometry, counting of naturally occurring total body 40K, and body density by underwater weighing in 25 healthy adult subjects. We found agreement between fat percentage (and lean body mass) by DEXA and the three established measurements modalities; mean differences were (-5.3 to -0.4%) and (-0.7 to 2.5 kg) for fat percentage and lean body mass, respectively. We conclude that DEXA provides a new method of measuring body composition with precision and accuracy errors, which are compatible with the application of DEXA in group research studies and probably also in clinical measurements of the single subject.

The meaning and measurement of lean body mass

Methods of measuring lean body mass have evolved greatly in the past decade. Because all practical methods of measurement are indirect (i.e., not involving carcass analysis), appropriate models of body composition must be applied. Today's improved precision is due both to better instrumentation and to improved models based on partition of the body into its constituent compartments. With this improved methodology has come the recognition that loss of lean body mass is associated with survival in starvation, acute illness, and aging. In addition, correlations of lean body mass with immune competence and functional status are beginning to emerge. It remains to be proven that changes in lean body mass in aging and disease independently determine outcome. Interventions that preserve or normalize lean body mass could be important for preservation of vigorous functional status.

Comparison of dual-photon absorptiometry systems for total-body bone and soft tissue measurements: dual-energy X-rays versus gadolinium 153

A total of 81 subjects (41 males and 40 females) were scanned by dual-photon absorptiometry by 153Gd source (DPA; Lunar DP4) and by dual-energy x-ray absorptiometry (DEXA; Lunar-DPX) within a 24 h period. Total-body bone mineral density (TBMD), calcium content (Ca), and soft tissue mass (ST) were determined with a precision of about 1-1.5% using DPA and 0.5-1.0% using DEXA. Measurements of TBMD, Ca, ST, bone area (area), percentage fat, and regional bone mineral densities (BMD) were compared. Paired t-tests showed small but significant differences between all measurements. Correlations (r) for TBMD, Ca, area, ST, percentage fat, arm BMD, leg BMD, and trunk BMD were 0.99, 0.99, 0.97, 0.99, 0.97, 0.99, 0.99, and 0.98. There were small systematic differences for TBMD (less than 1%), calcium (3%), bone area (3%), soft tissue mass (7%), and percentage fat (9%) between the two approaches. Regression equations are given relating these measurements.

Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity

Forearm and systemic adipose tissue free fatty acid (FFA) release was measured in eight nonobese, six lower-body obese, and eight upper-body obese women under basal, hyperinsulinemic, and hypoinsulinemic conditions to determine whether forearm fat is regulated in a similar manner as whole body fat.

RESULTS

Adipose tissue palmitate release was greater from forearm than whole body (5.97 +/- 0.75 vs. 3.84 +/- 0.34 mumol.kg fat-1.min-1, respectively, P less than 0.005, n = 22 subjects). Systemic palmitate release, relative to fat mass, was significantly (P less than 0.01) greater in nonobese than upper-body obese, and upper-body obese than lower-body obese women, and forearm adipose tissue palmitate release followed the same pattern. Hyperinsulinemia suppressed systemic and forearm lipolysis to similar degrees, however, hypoinsulinemia consistently increased systemic palmitate flux without increasing forearm palmitate release. These results confirm the heterogeneity of adipose tissue in an in vivo model and emphasize the need to consider which adipose tissue depots are responsible for the differences in systemic FFA flux in obese and nonobese humans.